NDC 0409-7447 - Cimetidine in Sodium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-7447
- Package NDCs from labels
- 0409-7447-16
- Manufacturer
- HOSPIRA, INC.
- Effective date
- 2006-04-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CIMETIDINE in 0.9% Sodium Chloride Injection, USP | HOSPIRA, INC. | 2006-04-13 | Human prescription drug label |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Cimetidine | ACTIVE INGREDIENT | 80061L1WGD | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Cimetidine | ACTIVE MOIETY | 80061L1WGD | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | CIMETIDINE IN SODIUM CHLORIDE (CIMETIDINE AND SODIUM CHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carboplatin | CARBOPLATIN | Hospira, Inc. | 47677091-fd20-49af-933c-c9dd2be21de9 | 2024-08-21 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Gemcitabine | GEMCITABINE | Hospira, Inc. | d16907e7-a8c8-4039-ace4-cf4e24ba68c0 | 2024-08-16 | Warnings, Adverse reactions | Hospira, Inc. |
| GEMCITABINE | GEMCITABINE | Hospira, Inc. | a625c92b-c569-4b98-8d2e-2b3f5e12b34f | 2024-08-16 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | f55bd888-5e01-474d-871b-24654c070178 | 2024-07-24 | Warnings, Adverse reactions | Sodium Chloride |
| PEMETREXED | PEMETREXED | Hospira, Inc. | 3e087418-69ff-47fa-93c2-f28699309433 | 2024-07-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 83994d0c-8484-4505-abb5-8a384ed12288 | 2024-07-22 | Warnings, Adverse reactions | Sodium chloride |
| sodium chloride | SODIUM CHLORIDE | Becton Dickinson and Company | 8df7dcf6-8714-6caf-e053-2995a90ab8cc | 2024-07-15 | Warnings, Adverse reactions | sodium chloride |
| TAZICEF | CEFTAZIDIME | Hospira, Inc. | 1ab5ae3e-e303-4499-4c89-472d7cc1e46c | 2024-07-04 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2024-06-24 | Warnings, Adverse reactions | Sodium Chloride |
| Carboplatin | CARBOPLATIN | Hospira, Inc. | c3ae9880-44bb-4f4e-93d8-8a5e21708a30 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| LEVETIRACETAM | LEVETIRACETAM | Hospira, Inc. | f1935bc8-30ce-4b51-8a4c-0f12ce9000a6 | 2024-06-05 | Warnings, Adverse reactions | Hospira, Inc. |
| Aztreonam | AZTREONAM | Hospira, Inc. | d4500795-3b07-4a7d-b432-73cafbb3dbc6 | 2024-06-03 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 239a5af1-7498-480f-862c-ab7c3d89d183 | 2024-05-21 | Warnings, Adverse reactions | Sodium chloride |
| Sodium chloride | SODIUM CHLORIDE | Becton Dickinson and Company | ebc8b008-a8b3-4c41-89e4-b413f7aab89f | 2024-05-21 | Warnings, Adverse reactions | Sodium chloride |
| LEVETIRACETAM | LEVETIRACETAM | Hospira, Inc. | ed1b74a8-2a9b-4315-b051-673c7941cb13 | 2024-05-14 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | B. Braun Medical Inc. | 47a0313f-36df-4fa6-a828-c9e1946ba9b0 | 2024-05-08 | Warnings, Adverse reactions | Sodium Chloride |
| Sodium Chloride | SODIUM CHLORIDE | B. Braun Medical Inc. | 7f22c06b-6b4d-4b49-a4b2-d2169f2bd653 | 2024-05-07 | Warnings, Adverse reactions | Sodium Chloride |
| Sodium Chloride | SODIUM CHLORIDE | B. Braun Medical Inc. | f2475fa3-ab1d-4b81-8127-b58cd0790a54 | 2024-05-06 | Warnings, Adverse reactions | Sodium Chloride |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | c1e52670-c85e-4f19-a2e9-bf9abd7c3727 | 2024-04-23 | Warnings, Adverse reactions | Sodium chloride |
| carboprost tromethamine | CARBOPROST TROMETHAMINE | Hospira, Inc. | e5054c6a-c54e-4ddf-8280-a154b90cac07 | 2024-04-15 | Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.